Table 1.

General characteristics and subgroup analysis of the patients with (n=19) and without (n=108) granulomatous inflammation on the specimen of resected lung

	Total	Only cancer	Coexisting granulomatous inflammation with lung cancer	p Value
Number	127	108	19
Age	68 (26–89)	69 (26–89)	63 (40–84)	0.06
Gender—males	74 (58.2%)	62 (57.4)	12 (63.1)	0.78
Location of lesion
Right upper lobe	35 (27.5)	28 (25.9)	7 (36.8)	0.40
Right middle lobe	13 (10.2)	11 (10.1)	2 (10.5)	1.0
Right lower lobe	19 (14.9)	17 (15.7)	2 (10.5)	0.73
Left upper lobe	23 (18.1)	21 (19.4)	2 (10.5)	0.52
Lingula	2 (1.5)	2 (1.8)	0	1.0
Left lower lobe	20 (15.7)	15 (13.8)	5 (26.3)	0.18
Bilateral	5 (3.9)	3 (2.7)	2 (10.5)	0.16
Type of surgery
Wedge resection	44 (34.6)	36 (33.3)	8 (42.1)	0.42
Lobectomy	45 (35.4)	36 (33.3)	8 (42.1)	0.42
Others	1 (0.07)	36 (33.3)	2 (10.5)	0.16
Histology type
Adenocarcinoma	82 (64.5)	71 (66)	11 (57.8)	0.60
Squamous cell carcinoma	12 (9.4)	10 (9)	–	0.35
Large-cell carcinoma	2 (1.5)	1 (1)	1 (5.2)	0.27
Others	27 (21.2)	23 (21)	4 (21)	1.0
Died	18 (14.1)	15 (14)	3 (16)	0.73
History of tuberculosis	4 (3.1)	2 (1.8)	2 (11)	0.10
History of non-tuberculous mycobacteria	3 (2.3)	1 (0.09)	2 (11)	0.05
Chemotherapy	30 (23.6)	23 (21.2)	7 (36.8)	0.15
Survival, median (range)—days	451 (22–2452)	449 (29–2452)	478 (22–1569)	0.56
1-year survival	68 (53.5)	58 (54)	10 (53)	1.0
2-year survival	27 (21.2)	20 (19)	7 (37)	0.12
3-year survival	11 (8.6)	7 (6)	4 (21)	0.06
Tuberculosis treatment	1 (0.07)	0	1 (5.2)	0.14
Stage
I and II	97 (76.3)	84 (77.7)	13 (68.4)	0.38
IIIA	30 (23.6)	24 (22.2)	6 (31.5)	0.38
Granulomatous inflammation in parenchyma	19 (14.9)	–	19 (100)	–
Granulomatous inflammation in parenchyma and lymph nodes	5 (3.9)	–	5 (26.3)	–

Data presented as number (%) or median (range).